Products for Research Use Only

Eloralintide (sodium)

CAT: 0804-HY-P10798A-01Size: 1 mgDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:0804-HY-P10798A-01Size:1 mg
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Eloralintide (LY 3841136) sodium is an AMYR agonist, which is promising for research of type 2 diabetes and obesity[1].
Product Name Alternative
LY-3841136 (sodium)
UNSPSC
12352209
Target
Amylin Receptor
Related Pathways
GPCR/G Protein
Applications
Metabolism-protein/nucleotide metabolism
Field of Research
Metabolic Disease
Purity
99.72
Smiles
OC1=CC=C(C=C1)C[C@@H](C(N)=O)NC([C@H]([C@H](O)C)NC([C@H](CC(N)=O)NC([C@H](CO)NC(CNC([C@H](C(C)C)NC([C@H](CCC(O)=O)NC([C@H]([C@H](O)C)NC([C@H]2N(C([C@H]3N(C([C@H](CC(C)C)NC([C@H](CCCCNC(CC[C@@H](C(O)=O)NC(CC[C@@H](C(O)=O)NC(CCCCCCCCCCCCCCCCCCC(O)=O)=O)=O)=O)NC([C@H]4N(C(CNC([C@H](CC5=CC=CC=C5)NC([C@H](CC(N)=O)N(C([C@H](CC(N)=O)NC([C@H](CO)NC([C@H](CO)NC([C@H](CCCNC(N)=N)NC([C@H](C(C)C)NC([C@H](CC(C)C)NC([C@@](NC([C@H](CCC(O)=O)NC([C@H](C)NC([C@H](CC(C)C)NC([C@H](CCCN)NC(CNC([C@H]([C@H](O)C)NC([C@H](C)NC([C@H](CSCSC[C@@H]6NC(CC[C@@H](C(O)=O)N)=O)NC([C@H]([C@H](O)C)NC([C@H](C)NC([C@H]([C@H](O)C)NC([C@H](CC(N)=O)NC6=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)=O)(CC7=CC=CC=C7)C)=O)=O)=O)=O)=O)=O)=O)C)=O)=O)=O)CCC4)=O)=O)=O)CCC3)=O)CCC2)=O)=O)=O)=O)=O)=O)=O)=O.[Na].[x]
Molecular Formula
C201H319N49O65S2.xNa
Molecular Weight
4526.10 (free base)
References & Citations
[1]A Phase 2, Parallel-Group, Double-Blind, Placebo-Controlled Study to Investigate Weight Management With LY3841136 and Tirzepatide, Alone or in Combination, in Adult Participants With Obesity or Overweight With Type 2 Diabetes.
Shipping Conditions
Blue Ice
Storage Conditions
-80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
Scientific Category
Peptides
Clinical Information
Phase 2